Frequency Therapeutics scores $42 mln Series B


Woburn, Massachusetts-based Frequency Therapeutics, a clinical-stage biotechnology company, has raised $42 million in Series B financing. Taiwania Capital Management and Axil Capital led the round with participation from Yonjin Capital, DF Investments, Polaris Founders Capital, Alexandria Venture Investments, CoBro Ventures, Korea Investment Partners and Emigrant Capital.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!